Bioton (LTS:0DTR) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


LTS:0DTR Bioton SA LTS:0DTR
68 GF Score
Price zł3.43
GF Value zł4.23
! 3 Warning Signs
View Full Analysis

What is Bioton Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bioton's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

LTS:0DTR vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Bioton's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioton Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Bioton's Margin of Safety % (DCF Earnings Based) falls into.


LTS:0DTR
68GF Score
Bioton SA LTS:0DTR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 19% below its estimated GF Value™ of zł4.23.

Key valuation signals for LTS:0DTR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: zł4.23 vs. price of zł3.43 (19% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
68GF Score

Get the complete analysis for LTS:0DTR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.23
GF Value